Hello, Guest
Login
Sign Up
 
 

Today's Market Winners and Losers (AMRN, ISIS, ARRY, MTG)

HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

 
 
Repost This

Los Angelas, CA -- (SBWIRE) -- 11/09/2012 -- Amarin Corporation plc (NASDAQ:AMRN) is currently trading at $11.1 up 8.2% in pre-market on 3440 shares traded. AMRN is trading -18.18% below its 50 day moving average and -10.83% below its 200 day moving average. AMRN is -35.71% below its 52-week high and 71.29% above its 52-week low. Amarin Corporation PLC (NASDAQ:AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.

How Should Investors React To AMRN Now? Find Out Here

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. ISIS Pharmaceuticals Inc (NASDAQ:ISIS) decreased 5.43% and closed at $7.67 on a traded volume 1.85 million shares.Recently, the Company announced third quarter results. Revenue was $11.6 million compared to $20.7 million in the same period in 2011.The operating expenses were $37.6 million compared to $40.7 million in the same period in 2011.The net loss was $37.6 million compared to $26.9 million in the same period in 2011.

How Should Investors Trade ISIS Now? Find Out Here

Array BioPharma Inc. (NASDAQ:ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Array Biopharma Inc. (NASDAQ:ARRY) retreated 10.59 percent in premarket after the company priced an underwritten public offering of 18 million shares at $3.65 each.

Can ARRY Extend This Losing Stream? Find Out Here

MGIC Investment Corp. (NYSE:MTG) remains challenging, and the stock has fallen 15% from the end of October. Mortgage claim costs may not be going away any time soon, and the tentative Freddie Mac settlement already has come and gone as far as the share price is concerned. A softening economy is now a risk all over again to this insurer. While its book value is still twice its share price, this one keeps losing money and revenues are expected to continue declining. At $1.68, its 52-week range is $0.66 to $5.15. It was a penny stock before, and not that long ago.

Can MTG Jump Again? Find Out Here

SUBTITLE
HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com